Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data

Morbidity and mortality after allogeneic hematopoietic cell transplantation (alloHCT) are still essentially affected by reactivation of cytomegalovirus (CMV). We evaluated 80 seropositive patients transplanted consecutively between March 2018 and March 2019 who received letermovir (LET) prophylaxis...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of hematology 2021-08, Vol.100 (8), p.2087-2093
Hauptverfasser:	Derigs, Patrick, Radujkovic, Aleksandar, Schubert, Maria-Luisa, Schnitzler, Paul, Schöning, Tilman, Müller-Tidow, Carsten, Hegenbart, Ute, Schönland, Stefan O., Luft, Thomas, Dreger, Peter, Schmitt, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral drugs Cytomegalovirus Disease prevention Hematology Life Sciences & Biomedicine Medicine Medicine & Public Health Oncology Original Original Article Patients Science & Technology Stem cell transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!